Background Treatment with systemic corticosteroids in patients with acute exacerbations of
chronic obstructive pulmonary disease (COPD) is associated with debilitating adverse …

Inhaled corticosteroids (ICSs) remain controversial in COPD, although recent clinical trials
have consistently found that they reduce chronic respiratory symptoms and, in some …

Inhaled corticosteroids (ICS) are now very widely used in high doses in the management of
COPD patients. In sharp contrast to the situation in asthma, ICS provide little or no benefit in …

The use of inhaled corticosteroids (ICS) for the maintenance of bronchodilator treatment in
patients with chronic obstructive pulmonary disease (COPD) is controversial. While some …

Background Inhaled corticosteroids (ICS) are indicated for prevention of exacerbations in
patients with COPD, but they are frequently overprescribed. ICS withdrawal has been …

Introduction Chronic obstructive pulmonary disease (COPD) is one of the main causes of
death and disability worldwide. Many treatment options are now available, but criteria for …

Background Inhaled corticosteroids (ICSs) have been used widely in the maintenance
therapy of COPD. However, whether inhaled therapy containing ICSs can reduce the all …

Inhaled corticosteroids (ICS) have had an important impact on the management of chronic
obstructive pulmonary disease (COPD). When combined with an inhaled long-acting b …

Background Inhaled corticosteroids (ICS) have been shown to decrease the occurrence of
COPD exacerbations. However, the relationship of baseline lung function and reduction of …

Background The use of inhaled corticosteroids (ICS) in combination with bronchodilators in
patients with COPD has been shown to decrease the rate of disease exacerbations and to …